Rubin, E. J., Yeku, O. O., Morrissey, S. (2025). NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors. New England Journal of Medicine. https://doi.org/10.1056/nejme2411486